Literature DB >> 25869945

Zolpidem : Forensic aspects for the toxicologist and pathologist.

Timothy P Rohrig1, Christine M Moore.   

Abstract

Zolpidem (Ambien), a nonbenzodiazepine hypnotic, is indicated for the short-term treatment of insomnia. Because it has become the most widely prescribed sleep aid in the United States, it is being increasingly detected in a variety of forensic specimens, and its interaction with other medications is being questioned. We present a comprehensive overview of the basic chemistry, pharmacokinetics, and pharmacodynamics of zolpidem; its interaction with other prescription drugs; its effects on driving and motor skills; and its analysis and interpretation in forensic casework.

Entities:  

Year:  2005        PMID: 25869945     DOI: 10.1385/FSMP:1:2:081

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.456


  62 in total

1.  Coadministration of short-term zolpidem with sertraline in healthy women.

Authors:  S Allard; S M Sainati; B F Roth-Schechter
Journal:  J Clin Pharmacol       Date:  1999-02       Impact factor: 3.126

2.  Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection.

Authors:  Teemu Gunnar; Sirpa Mykkänen; Kari Ariniemi; Pirjo Lillsunde
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-07-05       Impact factor: 3.205

3.  The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics.

Authors:  A A Piergies; J Sweet; M Johnson; B F Roth-Schechter; S Allard
Journal:  Int J Clin Pharmacol Ther       Date:  1996-04       Impact factor: 1.366

4.  Zolpidem distribution in postmortem cases.

Authors:  B Levine; S C Wu; J E Smialek
Journal:  J Forensic Sci       Date:  1999-03       Impact factor: 1.832

Review 5.  Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.

Authors:  G Hajak; W E Müller; H U Wittchen; D Pittrow; W Kirch
Journal:  Addiction       Date:  2003-10       Impact factor: 6.526

Review 6.  Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone.

Authors:  David R Drover
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Fatal intoxications in a Swedish forensic autopsy material during 1992-2002.

Authors:  Anna Jönsson; Per Holmgren; Johan Ahlner
Journal:  Forensic Sci Int       Date:  2004-06-30       Impact factor: 2.395

Review 8.  Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes.

Authors:  D J Sanger; J Benavides; G Perrault; E Morel; C Cohen; D Joly; B Zivkovic
Journal:  Neurosci Biobehav Rev       Date:  1994       Impact factor: 8.989

9.  Enantioselective determination of zopiclone and its metabolites in urine by capillary electrophoresis.

Authors:  G Hempel; G Blaschke
Journal:  J Chromatogr B Biomed Appl       Date:  1996-01-12

10.  Acute overdose of zolpidem.

Authors:  C L Winek; W W Wahba; J K Janssen; L Rozin; V Rafizadeh
Journal:  Forensic Sci Int       Date:  1996-04-23       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.